Heartbeat Labs

Heartbeat Labs is a Berlin-based venture capital firm established in 2017 that focuses on seed and early-stage investments in the healthcare sector, particularly in digital health, life sciences, and digital pharmaceuticals. The firm collaborates with agile teams comprising entrepreneurs, medical specialists, and technology experts to launch multiple digital health companies each year. Heartbeat Labs provides seed funding ranging from €0.5 to €5 million, along with access to a distinctive network of investors and operational support in areas such as marketing, human resources, finance, and regulatory affairs. With a track record of building over 20 successful internet companies, Heartbeat Labs aims to harness digitization to enhance the healthcare industry in Germany.

Johannes Keienburg

Managing Director

Hendrik Krawinkel

Co-Founder and Managing Director

11 past transactions

Betriebsarzt Service

Series A in 2022
Betriebsarzt Service offer you an uncomplicated, high-quality and reliable occupational health and safety-related care adapted to the needs of your employees and your company. They specialize in companies in growth and consolidation phases as well as industries that are subject to rapid change. Acute needs, such as the examination of electrical equipment, medical check-ups and all other occupational health and safety services, you can book with us individually!

CureSkin

Series A in 2022
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.

Farmako

Seed Round in 2018
Farmako GmbH is a research-based pharmaceutical company and distributor of medical cannabis, founded in 2018 and headquartered in Frankfurt, Germany, with an additional office in London, United Kingdom. The company focuses on developing alternative medicines utilizing cannabis formulations, positioning itself as a provider of natural remedies. Farmako aims to become a vertically integrated leader in the European medical cannabis market, operating in countries with established legal frameworks for this industry. It places a strong emphasis on innovation through research and development, striving to enhance the therapeutic options available to doctors, patients, and pharmacists. Additionally, Farmako is involved in conducting medical trials to further validate the efficacy of cannabinoid therapies.

BetterDoc

Venture Round in 2018
BetterDoc GmbH, founded in 2012 and based in Cologne, Germany, is a leading provider of medical expert referrals in the country. The company operates an online platform that facilitates consultations among doctors, allowing them to share insights on treatment options for various health conditions. BetterDoc focuses on generating, processing, and analyzing a wide range of healthcare quality data, which aids in identifying the most suitable medical experts for patients' specific health issues. By evaluating the outcome quality for individual cases, BetterDoc ensures that patients can make informed decisions when selecting healthcare providers, ultimately enhancing the effectiveness of their treatment.

Nebula Genomics

Series A in 2018
Nebula Genomics is a company that focuses on human genome sequencing and health data, aiming to create a comprehensive online marketplace for genomic information. Founded in 2016 by Harvard genomics pioneer George Church and his colleagues, the company is headquartered in San Francisco, California, with additional offices in Boston, Massachusetts. Nebula Genomics utilizes blockchain technology to empower consumers by allowing them to maintain control over their genomic data and receive compensation for its use. The platform aggregates extensive genetic information, enabling researchers to analyze data for accelerated drug development and personalized medicine. The company’s DNA sequencing technology covers all genes, regulatory regions, the Y chromosome, and mitochondrial DNA, facilitating in-depth genetic analysis and variant exploration.

Caresyntax

Venture Round in 2018
Caresyntax Inc. is a Boston-based company that provides a digital surgery platform to enhance surgical performance in hospitals and ambulatory surgical centers. Founded in 1991, it leverages data from over 1,600 hospitals globally to deliver insights that improve patient outcomes and operational efficiency. The platform integrates various data sources, including video, audio, clinical, and operational data, enabling real-time analysis and decision-making during surgeries. Caresyntax offers solutions such as qvident, a performance management software, and PRIME365, a comprehensive integration platform that consolidates surgical data and content. With a focus on automating workflows and reducing surgical variability, Caresyntax supports over 4,000 operating rooms and has facilitated millions of surgical procedures worldwide. The company’s HIPAA-compliant software can be deployed on-premise, in the cloud, or in a hybrid format, making it adaptable to diverse healthcare environments.

Medlanes

Series A in 2018
Medlanes is an online medical consultation service that enables users to connect with doctors from anywhere at any time. Through its app, patients can request medical advice and organize home visits from healthcare professionals. The service primarily caters to private patients and self-payers, offering an affordable way to access medical guidance. By collaborating with emergency doctors, Medlanes facilitates timely and convenient healthcare solutions, ensuring that patients receive the support they need without unnecessary delays.

Mimi Hearing Technologies

Series A in 2018
Mimi Hearing Technologies, founded in 2014 and based in Berlin, Germany, specializes in developing hearing enhancement technology and software for smartphones. The company's flagship product, Mimi.io, is an application that enables users to conduct hearing tests, experiment with different hearing enhancement profiles, and understand the challenges of hearing loss. Mimi is recognized as a leader in digital hearing tests and sound personalization, with its apps certified as medical devices in Europe. Having amassed over one million app downloads from 150 countries, Mimi has created one of the world's largest databases of digital hearing profiles. The company's technology, Mimi Defined™, optimizes individual hearing experiences by personalizing sound. This software can be integrated into various audio products, including headphones, TVs, smartphones, and streaming services. Mimi Hearing Technologies has received numerous international awards for its innovative products and integrations.

Daatrics

Seed Round in 2017
Daatrics is a technology company focused on providing innovative monitoring solutions for caregivers and families. The company offers the Neebo product line, which consists of small, multifunctional wearable devices designed to continuously monitor a child's vital activities. These devices track essential parameters such as sound, thermal comfort, heart rate, and blood oxygen levels in real time, ensuring that parents and caregivers are informed about their child's status, even when close supervision is not possible. Notably, Daatrics' devices operate without emitting chronic electromagnetic radiation, prioritizing the health and safety of children.

CureSkin

Seed Round in 2017
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.

Moodpath

Venture Round in 2016
You’re going through a difficult phase in life and are worried about your mental health? Moodpath is a leading depression app and accompanies you on your way out of depression. Moodpath screens your well-being by asking questions on a daily basis. The screening makes you more conscious about your thoughts, feelings and emotions. After two weeks, you receive an electronic doctor letter. This letter will make your conversation with a professional much easier. More than 150 psychological exercises and videos give you a better understanding of your moodpath and strengthen your mental health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.